Compound Detail
CHEMBL4298153
NIROGACESTAT HYDROBROMIDE 💊 Approved Drug
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
💊 Approved Drug
Br.Br.CCC[C@H](N[C@H]1CCc2cc(F)cc(F)c2C1)C(=O)Nc1cn(C(C)(C)CNCC(C)(C)C)cn1
Basic Information
| ChEMBL ID | CHEMBL4298153 |
| Name | NIROGACESTAT HYDROBROMIDE |
| Phase | Approved |
| Structure Type | MOL |
| InChI Key | LXEYYZYDWLAIPW-KBVFCZPLSA-N |
| Therapeutic | ✓ Yes |
| Parent Compound | CHEMBL1770916 |
| Active Moiety | CHEMBL1770916 |
0
Targets
0
Activities
0
Assay Types
0
PK Parameters
0
Publications
4
Known Names
2
Indications
1
Mechanisms
Molecular Properties
489.7
MW (Da)
4.79
ALogP
5
HBA
3
HBD
71.0
PSA (Ų)
0.45
QED
0
Ro5 Violations
10
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| First Approval | 2023 |
| Availability | Prescription |
| Chirality | Single Enantiomer |
Mechanism of Action
| Mechanism | Action Type | Target | Direct | Efficacy |
|---|---|---|---|---|
| Gamma-secretase inhibitor | INHIBITOR | Gamma-secretase | ✓ | ✓ |
Indications
Desmoid Tumors Neoplasms
Data from ChEMBL 36 via Core Engine